Ampio Pharmaceuticals, Inc.
5445 DTC Parkway, P4
Greenwood Village
Colorado
80111
United States
Tel: 303-418-1000
Fax: 303-418-1001
Website: http://www.ampiopharma.com/
310 articles about Ampio Pharmaceuticals, Inc.
-
Ampio Pharmaceuticals, Inc. Release: Favorable Clinical Trial Results for Ampion(TM) in Treatment of Osteoarthritis (AIK) Allows Testing as a Monotherapy Against "Standard of Care," Ahead of Schedule
10/26/2011
-
Ampio Pharmaceuticals, Inc. Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina(TM)
10/18/2011
-
Ampio Pharmaceuticals, Inc. Completes Treatment Phase of the Ampion(TM) -in-Knee Clinical Trial for Osteoarthritis
10/13/2011
-
Ampio Pharmaceuticals, Inc. Announces the Presentation of a Publication on Ampion(R), Its Drug Candidate to Address Human Inflammation, at the American Association of Orthopedic Surgery
10/10/2011
-
Ampio Pharmaceuticals, Inc. Appoints Mark G. Edwards to Its Board of Directors
9/28/2011
-
Ampio Pharmaceuticals, Inc. Announces Positive Results From 12-Week Open Label Extension Study of Zertane(TM) in Patients With Premature Ejaculation.
9/26/2011
-
Ampio Pharmaceuticals, Inc. Announces Positive Results From 12-Week Open Label Extension Study of Zertane in Patients With Premature Ejaculation
9/26/2011
-
Ampio Pharmaceuticals, Inc.' Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane(TM) in South Korea
9/8/2011
-
Ampio Pharmaceuticals, Inc. Release: Zertane(TM) Clinical Results Published in the Journal European Urology
8/30/2011
-
Ampio Pharmaceuticals, Inc. Expands Business Development Capabilities with the Hiring of Deborah Knobelman, Ph.D as Chief Business Officer
8/22/2011
-
Ampio Pharmaceuticals, Inc. Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
7/6/2011
-
Phase III Study Shows Ampio Pharmaceuticals, Inc. Drug Improves Ejaculation Times in Men with PE
6/27/2011
-
Ampio Pharmaceuticals, Inc. Set to Join Russell 3000 Index
6/16/2011
-
Ampio Pharmaceuticals, Inc. Appoints New Independent Director
6/8/2011
-
Ampio Pharmaceuticals, Inc. Announces Initiation of Phase 1B Clinical Trial for Its Anti-inflammatory Drug Ampion™
5/31/2011
-
Ampio Pharmaceuticals, Inc. Completes Evaluation of Data From Phase III Clinical Trials of Zertane(TM) for Treatment of the Most Common Male Sexual Dysfunction, Premature Ejaculation
5/23/2011
-
Ampio Pharmaceuticals, Inc. to Begin Trading on the NASDAQ Capital Market
5/19/2011
-
Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market
5/17/2011
-
Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement
4/19/2011
-
Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011
4/1/2011